Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig M Horbinski

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Investigation|March 16, 2026
Mismatch repair deficiency reshapes glioblastoma through immune suppression rather than hypermutationAndrew Li, Thomas K Sears, Craig M Horbinski
Journal of Neuro-Oncology|August 23, 2021
IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostatThomas K Sears, Craig M Horbinski, Kevin D Woolard
World Neurosurgery|May 25, 2019
Rapid Development of an Aneurysm at the Anastomotic Site of a Superficial Temporal Artery to Middle Cerebral Artery Bypass: Case Report and Literature ReviewMatthew B Potts, Craig M Horbinski, Babak S Jahromi
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 22, 2017
Therapeutic Hypothesis Testing With Rodent Brain Tumor ModelsDerek A Wainwright, Craig M Horbinski, Rintaro Hashizume, et al.
Surgical Neurology International|August 6, 2020
Intraventricular adult <i>Taenia solium</i> causing hydrocephalus: A case reportKetan Yerneni, Constantine Karras, Hannah K Weiss, et al.
The Neurologist|September 1, 2018
Response to BRAF/MEK Inhibition After Progression With BRAF Inhibition in a Patient With Anaplastic Pleomorphic XanthoastrocytomaFaiz Hussain, Craig M Horbinski, Steven J Chmura, et al.
Human Pathology|July 13, 2016
Association of epithelial-mesenchymal transition and nuclear cofilin with advanced urothelial cancerPatrick J Hensley, Daniel Zetter, Craig M Horbinski, et al.
Drugs|October 11, 2019
Immunotherapy Against Gliomas: is the Breakthrough Near?Rimas V Lukas, Derek A Wainwright, Craig M Horbinski, et al.
Current Neurology and Neuroscience Reports|May 24, 2020
The Essentials of Molecular Testing in CNS Tumors: What to Order and How to Integrate ResultsAlexander Z Feldman, Lawrence J Jennings, Nitin R Wadhwani, et al.
Immunotherapy|August 4, 2016
Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapyZhengming Xiong, Elisabet Ampudia-Mesias, Rob Shaver, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Investigation|March 16, 2026
Mismatch repair deficiency reshapes glioblastoma through immune suppression rather than hypermutationAndrew Li, Thomas K Sears, Craig M Horbinski
Journal of Neuro-Oncology|August 23, 2021
IDH1 mutant glioma is preferentially sensitive to the HDAC inhibitor panobinostatThomas K Sears, Craig M Horbinski, Kevin D Woolard
World Neurosurgery|May 25, 2019
Rapid Development of an Aneurysm at the Anastomotic Site of a Superficial Temporal Artery to Middle Cerebral Artery Bypass: Case Report and Literature ReviewMatthew B Potts, Craig M Horbinski, Babak S Jahromi
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 22, 2017
Therapeutic Hypothesis Testing With Rodent Brain Tumor ModelsDerek A Wainwright, Craig M Horbinski, Rintaro Hashizume, et al.
Surgical Neurology International|August 6, 2020
Intraventricular adult <i>Taenia solium</i> causing hydrocephalus: A case reportKetan Yerneni, Constantine Karras, Hannah K Weiss, et al.
The Neurologist|September 1, 2018
Response to BRAF/MEK Inhibition After Progression With BRAF Inhibition in a Patient With Anaplastic Pleomorphic XanthoastrocytomaFaiz Hussain, Craig M Horbinski, Steven J Chmura, et al.
Human Pathology|July 13, 2016
Association of epithelial-mesenchymal transition and nuclear cofilin with advanced urothelial cancerPatrick J Hensley, Daniel Zetter, Craig M Horbinski, et al.
Drugs|October 11, 2019
Immunotherapy Against Gliomas: is the Breakthrough Near?Rimas V Lukas, Derek A Wainwright, Craig M Horbinski, et al.
Current Neurology and Neuroscience Reports|May 24, 2020
The Essentials of Molecular Testing in CNS Tumors: What to Order and How to Integrate ResultsAlexander Z Feldman, Lawrence J Jennings, Nitin R Wadhwani, et al.
Immunotherapy|August 4, 2016
Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapyZhengming Xiong, Elisabet Ampudia-Mesias, Rob Shaver, et al.
Pageof 9